Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication August 17, 2021
- Revision received December 28, 2021
- Published online September 1, 2022.
Article Versions
- previous version (January 6, 2022 - 13:04).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Julia Driessen*,1,
- Gerben J.C. Zwezerijnen*,2,
- Heiko Schöder3,
- Esther E.E. Drees4,
- Marie José Kersten1,
- Alison J. Moskowitz5,
- Craig H. Moskowitz6,
- Jakoba J. Eertink7,
- Henrica C.W. de Vet8,
- Otto S. Hoekstra2,
- Josée M. Zijlstra7 and
- Ronald Boellaard2
- 1Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE (Lymphoma and Myeloma Center, Amsterdam), Cancer Center Amsterdam, Amsterdam, The Netherlands;
- 2Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands;
- 3Department of Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
- 4Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands;
- 5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;
- 6Department of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida;
- 7Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands; and
- 8Department of Epidemiology and Data Science, Amsterdam Public Health research institute, Amsterdam, Netherlands
- For correspondence or reprints, contact Ronald Boellaard (r.boellaard{at}amsterdamumc.nl).
↵* Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation
- Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy
- Is 18F-FDG Metabolic Tumor Volume in Lymphoma Really Happening?